Correlation Between Exelixis and Corcept Therapeutics

Can any of the company-specific risk be diversified away by investing in both Exelixis and Corcept Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Corcept Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Exelixis and Corcept Therapeutics Incorporated, you can compare the effects of market volatilities on Exelixis and Corcept Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Corcept Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Corcept Therapeutics.

Diversification Opportunities for Exelixis and Corcept Therapeutics

0.89

Correlation Coefficient

Exelixis  Corcept Therapeutics

Very poor diversification

The 3 months correlation between Exelixis and Corcept is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Corcept Therapeutics Incorpora in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corcept Therapeutics and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Corcept Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corcept Therapeutics has no effect on the direction of Exelixis i.e., Exelixis and Corcept Therapeutics go up and down completely randomly.

Pair Corralation between Exelixis and Corcept Therapeutics

Given the investment horizon of 90 days Exelixis is expected to under-perform the Corcept Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Exelixis is 2.02 times less risky than Corcept Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Corcept Therapeutics Incorporated is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  5,214  in Corcept Therapeutics Incorporated on October 6, 2024 and sell it today you would lose (128.00) from holding Corcept Therapeutics Incorporated or give up 2.45% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Exelixis  vs.  Corcept Therapeutics Incorpora

Exelixis

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Exelixis disclosed solid returns over the last few months and may actually be approaching a breakup point.

Corcept Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Corcept Therapeutics Incorporated are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Corcept Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Exelixis and Corcept Therapeutics

The main advantage of trading using opposite Exelixis and Corcept Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Corcept Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corcept Therapeutics will offset losses from the drop in Corcept Therapeutics' long position.

The idea behind Exelixis and Corcept Therapeutics Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.